Perineal Crohn's disease: An indicator of poor prognosis and potential proctectomy

Diseases of the Colon and Rectum

Volumn 52, Issue 4, 2009, Pages 646-650

  Figg, Ryan E ^a   Church, James M ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Colorectal Surgery ^*  (United States)

Author keywords

Crohn's colitis; Crohn's disease; Perianal fistulas

Indexed keywords

ANUS FISSURE; ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; EDEMA; FEMALE; GRACILIS FLAP; GRANULOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERINEAL CROHN DISEASE; PERINEUM; PERINEUM INJURY; PROGNOSIS; RECTUM RESECTION; SEPSIS; SEX DIFFERENCE; SKIN GRAFT; SMALL INTESTINE; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WOUND HEALING IMPAIRMENT; ADULT; PATHOLOGY; RECTUM; ULCER; WOUND DRAINAGE;

ANTIINFLAMMATORY AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; DRAINAGE; FEMALE; HUMANS; MALE; PERINEUM; PROGNOSIS; RECTUM; ULCER;

EID: 66849091424     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181a0a5bf     Document Type: Article

References (13)

1. Lockhart-Mummery HE. Symposium. Crohn's disease: anal lesions. Dis Colon Rectum 1975;18:200Y2.
2. Pikarsky AJ, Gervaz P, Wexner SD. Perianal Crohn's disease: a new scoring system to evaluate and predict outcome of surgical intervention. Arch Surg 2002;137:774Y7.
3. American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003;125:1503Y7.
4. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875Y80.
5. Lecomte T, Contou JF, Beaugerie L, et al. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine. Dis Colon Rectum 2003;46:1469Y75.
6. Moyes LH, Glen P, Pickford IR. Perineal metastatic Crohn's disease: a case report and review of the literature. Ann R Coll Surg Engl 2007;89:W1Y3.
7. Williams N, Scott NA, Watson JS, Irving MH. Surgical management of perineal and metastatic cutaneous Crohn's disease. Br J Surg 1993;80:1596Y8.
8. Kafity AA, Pellegrini AE, Fromkes JJ. Metastatic Crohn's disease: a rare cutaneous manifestation. J Clin Gastroenterol 1993;17:300Y3.
9. Topstad DR, Panaccione R, Heine JA, Johnson DR, MacLean AR, Buie WD. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum 2003;46:577Y83.
10. Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 2006;49:1837Y41.
11. Ardizzone S, Maconi G, Colombo E, Manzionna G, Bollani S, Bianchi Porro G. Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis 2004;10:91Y6.
12. Parsi MA, Lashner BA, Achkar JP, Connor JT, Brzezinski A. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease. Am J Gastroenterol 2004;99: 445Y9.
13. Rasul I, Wilson SR, MacRae H, Irwin S, Greenberg GR. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease. Am J Gastroenterol 2004;99:82Y8.